Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report.

Lichtenstein GR, Feagan BG, Mahadevan U, Salzberg BA, Langholff W, Morgan GJ, Safdi M, Nissinen R, Taillard F, Sandborn WJ, Cohen RD.

Am J Gastroenterol. 2018 Jul 19. doi: 10.1038/s41395-018-0202-9. [Epub ahead of print]

PMID:
30022113
2.

Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' reply.

Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M.

Aliment Pharmacol Ther. 2018 Aug;48(3):388-389. doi: 10.1111/apt.14855. No abstract available.

3.

Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative Colitis.

Mahadevan U, Dubinsky MC, Su C, Lawendy N, Jones TV, Marren A, Zhang H, Graham D, Clowse MEB, Feldman SR, Baumgart DC.

Inflamm Bowel Dis. 2018 Jul 2. doi: 10.1093/ibd/izy160. [Epub ahead of print]

PMID:
29982686
4.

Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.

Matro R, Martin CF, Wolf D, Shah SA, Mahadevan U.

Gastroenterology. 2018 May 29. pii: S0016-5085(18)34573-6. doi: 10.1053/j.gastro.2018.05.040. [Epub ahead of print]

PMID:
29857090
5.

Anti-TNF and thiopurine therapy in pregnant IBD patients does not significantly alter a panel of B-cell and T-cell subsets in 1-year-old infants.

Kattah MG, Milush JM, Burt T, McCabe RP Jr, Whang MI, Ma A, Mahadevan U.

Clin Transl Gastroenterol. 2018 Apr 3;9(4):143. doi: 10.1038/s41424-018-0018-3.

6.

Inflammatory Bowel Disease-Gastroenterology Diamond Jubilee Review.

Mahadevan U, Silverberg MS.

Gastroenterology. 2018 May;154(6):1555-1558. doi: 10.1053/j.gastro.2017.12.025. Epub 2018 Mar 15. Review. No abstract available.

PMID:
29550591
7.

Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines.

Beaulieu DB, Ananthakrishnan AN, Martin C, Cohen RD, Kane SV, Mahadevan U.

Clin Gastroenterol Hepatol. 2018 Jan;16(1):99-105. doi: 10.1016/j.cgh.2017.08.041. Epub 2017 Sep 1.

PMID:
28870657
8.

How to Get an Education in Inflammatory Bowel Disease During Fellowship: Expectations and Realities.

Mahadevan U.

Gastroenterology. 2017 Jun;152(8):1813-1816. doi: 10.1053/j.gastro.2017.04.031. Epub 2017 Apr 28. No abstract available.

PMID:
28461195
9.

Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study.

Bengtson MB, Aamodt G, Mahadevan U, Vatn MH.

Inflamm Bowel Dis. 2017 Jul;23(7):1225-1233. doi: 10.1097/MIB.0000000000001123.

PMID:
28452861
10.

Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply.

Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M.

Aliment Pharmacol Ther. 2017 May;45(9):1284. doi: 10.1111/apt.14054. No abstract available.

PMID:
28370036
11.

Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort.

Bengtson MB, Martin CF, Aamodt G, Vatn MH, Mahadevan U.

Dig Dis Sci. 2017 Aug;62(8):2063-2069. doi: 10.1007/s10620-017-4547-5. Epub 2017 Mar 22.

PMID:
28332106
12.

Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease.

Mahadevan U, Vermeire S, Lasch K, Abhyankar B, Bhayat F, Blake A, Dubinsky M.

Aliment Pharmacol Ther. 2017 Apr;45(7):941-950. doi: 10.1111/apt.13960. Epub 2017 Feb 7.

PMID:
28169436
13.

Inflammatory Bowel Disease 2017: Innovations and Changing Paradigms.

Colombel JF, Mahadevan U.

Gastroenterology. 2017 Feb;152(2):309-312. doi: 10.1053/j.gastro.2016.12.004. Epub 2016 Dec 10. No abstract available.

PMID:
27960091
14.
15.

Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.

Mahadevan U, McConnell RA, Chambers CD.

Gastroenterology. 2017 Feb;152(2):451-462.e2. doi: 10.1053/j.gastro.2016.10.013. Epub 2016 Oct 18.

PMID:
27769809
16.

Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients.

Mar JS, LaMere BJ, Lin DL, Levan S, Nazareth M, Mahadevan U, Lynch SV.

MBio. 2016 Aug 16;7(4). pii: e01072-16. doi: 10.1128/mBio.01072-16.

17.

The Birds, the Bees, and Inflammatory Bowel Disease: Preconception Care in Inflammatory Bowel Disease.

McConnell RA, Mahadevan U.

Clin Gastroenterol Hepatol. 2016 Sep;14(9):1293-5. doi: 10.1016/j.cgh.2016.05.028. Epub 2016 Jun 2. No abstract available.

PMID:
27264392
18.

Pregnancy and the Patient with Inflammatory Bowel Disease: Fertility, Treatment, Delivery, and Complications.

McConnell RA, Mahadevan U.

Gastroenterol Clin North Am. 2016 Jun;45(2):285-301. doi: 10.1016/j.gtc.2016.02.006. Review.

PMID:
27261899
19.

Detectable Drug Levels in Infants Exposed to Biologics: So What?

Kathpalia P, Kane S, Mahadevan U.

Gastroenterology. 2016 Jul;151(1):25-6. doi: 10.1053/j.gastro.2016.05.017. Epub 2016 May 20. No abstract available.

PMID:
27215654
20.

A Novel Decision Aid for Surgical Patients with Ulcerative Colitis: Results of a Pilot Study.

Cohan JN, Ozanne EM, Sewell JL, Hofer RK, Mahadevan U, Varma MG, Finlayson E.

Dis Colon Rectum. 2016 Jun;59(6):520-8. doi: 10.1097/DCR.0000000000000572.

PMID:
27145309
21.

Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor Therapy.

Carlucci JG, Halasa N, Creech CB, Dulek DE, Gómez-Duarte OG, Nelson GE, Talbot HK, Scalise ML, Scott PL, Mahadevan U, Beaulieu DB.

J Pediatric Infect Dis Soc. 2016 Jun;5(2):e9-e12. doi: 10.1093/jpids/piw001. Epub 2016 Mar 24.

PMID:
27012275
22.

The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response.

Sheibani S, Cohen R, Kane S, Dubinsky M, Church JA, Mahadevan U.

Dig Dis Sci. 2016 Jun;61(6):1622-7. doi: 10.1007/s10620-015-3992-2. Epub 2016 Jan 2.

PMID:
26725061
23.

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy.

Nguyen GC, Seow CH, Maxwell C, Huang V, Leung Y, Jones J, Leontiadis GI, Tse F, Mahadevan U, van der Woude CJ; IBD in Pregnancy Consensus Group; Canadian Association of Gastroenterology.

Gastroenterology. 2016 Mar;150(3):734-757.e1. doi: 10.1053/j.gastro.2015.12.003. Epub 2015 Dec 11. Review.

PMID:
26688268
24.

Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol.

Clowse ME, Wolf DC, Förger F, Cush JJ, Golembesky A, Shaughnessy L, De Cuyper D, Mahadevan U.

J Rheumatol. 2015 Dec;42(12):2270-8. doi: 10.3899/jrheum.140189. Epub 2015 Nov 1.

25.

In Reply.

Mahadevan U, Matro R.

Obstet Gynecol. 2015 Nov;126(5):1109. doi: 10.1097/AOG.0000000000001125. No abstract available.

PMID:
26488508
26.

Use of Immunomodulators and Biologics Before, During, and After Pregnancy.

McConnell RA, Mahadevan U.

Inflamm Bowel Dis. 2016 Jan;22(1):213-23. doi: 10.1097/MIB.0000000000000596. Review.

PMID:
26444103
27.

Care of the Pregnant Patient With Inflammatory Bowel Disease.

Mahadevan U, Matro R.

Obstet Gynecol. 2015 Aug;126(2):401-12. doi: 10.1097/AOG.0000000000000978. Review.

PMID:
26241432
28.

A molecular systems approach to modelling human skin pigmentation: identifying underlying pathways and critical components.

Raghunath A, Sambarey A, Sharma N, Mahadevan U, Chandra N.

BMC Res Notes. 2015 Apr 29;8:170. doi: 10.1186/s13104-015-1128-6.

29.

Confocal laser endomicroscopy for membrane-bound tumor necrosis factor predicts response to therapy in Crohn's disease.

Kattah MG, Mahadevan U.

Gastroenterology. 2015 May;148(5):1067-9. doi: 10.1053/j.gastro.2015.03.042. Epub 2015 Mar 28. No abstract available.

PMID:
25824357
30.

Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases.

Kavanaugh A, Cush JJ, Ahmed MS, Bermas BL, Chakravarty E, Chambers C, Clowse M, Curtis JR, Dao K, Hankins GD, Koren G, Kim SC, Lapteva L, Mahadevan U, Moore T, Nolan M, Ren Z, Sammaritano LR, Seymour S, Weisman MH.

Arthritis Care Res (Hoboken). 2015 Mar;67(3):313-25. doi: 10.1002/acr.22516. No abstract available. Erratum in: Arthritis Care Res (Hoboken). 2015 May;67(5):738.

31.

Editorial: the management of IBD during pregnancy and lactation.

Matro R, Mahadevan U.

Aliment Pharmacol Ther. 2014 Nov;40(10):1247-8. doi: 10.1111/apt.12964. No abstract available.

32.

A measured approach to Crohn's therapy: check levels and save.

Huang VW, Mahadevan U.

Gastroenterology. 2014 Nov;147(5):1174-5. doi: 10.1053/j.gastro.2014.09.006. Epub 2014 Sep 18. No abstract available.

PMID:
25240163
33.

Pharmacokinetics of biologics and the role of therapeutic monitoring.

Lin K, Mahadevan U.

Gastroenterol Clin North Am. 2014 Sep;43(3):565-79. doi: 10.1016/j.gtc.2014.05.007. Epub 2014 Jun 24. Review.

PMID:
25110259
34.

Insights into the molecular pathophysiology of inflammatory bowel disease: ATG16L1 suppresses nod-driven inflammation.

Kattah MG, Mahadevan U.

Gastroenterology. 2014 Aug;147(2):528-30. doi: 10.1053/j.gastro.2014.06.014. Epub 2014 Jun 20. No abstract available.

PMID:
24953625
35.

The use of biologic therapy in pregnancy: a gastroenterologist's perspective.

Hassid B, Mahadevan U.

Curr Opin Rheumatol. 2014 May;26(3):347-53. doi: 10.1097/BOR.0000000000000048. Review.

PMID:
24625373
36.

Immunoglobulin therapy for refractory Crohn's disease.

Shah S, Terdiman J, Gundling K, Mahadevan U.

Therap Adv Gastroenterol. 2014 Mar;7(2):99-102. doi: 10.1177/1756283X13504728. No abstract available.

37.

My treatment approach to management of the pregnant patient with inflammatory bowel disease.

Ng SW, Mahadevan U.

Mayo Clin Proc. 2014 Mar;89(3):355-60. doi: 10.1016/j.mayocp.2013.11.012. Review.

PMID:
24582194
38.

Popular exclusionary diets for inflammatory bowel disease: the search for a dietary culprit.

Hwang C, Ross V, Mahadevan U.

Inflamm Bowel Dis. 2014 Apr;20(4):732-41. doi: 10.1097/01.MIB.0000438427.48726.b0. Review.

PMID:
24562173
39.

Etrolizumab: anti-β7-a novel therapy for ulcerative colitis.

Lin KK, Mahadevan U.

Gastroenterology. 2014 Jan;146(1):307-9. doi: 10.1053/j.gastro.2013.11.013. Epub 2013 Nov 21. No abstract available.

PMID:
24269566
40.

Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis.

Truta B, Li DX, Mahadevan U, Fisher ER, Chen YY, Grace K, Velayos F, Terdiman JP.

Dig Dis Sci. 2014 Jan;59(1):135-45. doi: 10.1007/s10620-013-2866-8. Epub 2013 Oct 4.

PMID:
24091907
41.

Editorial: Are thiopurines and anti-TNFα agents safe to use in pregnant patients with inflammatory bowel disease?

Sheibani S, Mahadevan U.

Am J Gastroenterol. 2013 Mar;108(3):441-3. doi: 10.1038/ajg.2012.436.

PMID:
23459048
42.

Management of inflammatory bowel disease in pregnancy.

Ng SW, Mahadevan U.

Expert Rev Clin Immunol. 2013 Feb;9(2):161-73; quiz 174. doi: 10.1586/eci.12.103. Review.

PMID:
23390947
43.

Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease.

Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT.

Clin Gastroenterol Hepatol. 2013 Mar;11(3):286-92; quiz e24. doi: 10.1016/j.cgh.2012.11.011. Epub 2012 Nov 28.

44.

Micronutrient deficiencies in inflammatory bowel disease: from A to zinc.

Hwang C, Ross V, Mahadevan U.

Inflamm Bowel Dis. 2012 Oct;18(10):1961-81. doi: 10.1002/ibd.22906. Epub 2012 Apr 5. Review.

PMID:
22488830
45.

Protein interaction data curation: the International Molecular Exchange (IMEx) consortium.

Orchard S, Kerrien S, Abbani S, Aranda B, Bhate J, Bidwell S, Bridge A, Briganti L, Brinkman FS, Cesareni G, Chatr-aryamontri A, Chautard E, Chen C, Dumousseau M, Goll J, Hancock RE, Hannick LI, Jurisica I, Khadake J, Lynn DJ, Mahadevan U, Perfetto L, Raghunath A, Ricard-Blum S, Roechert B, Salwinski L, Stümpflen V, Tyers M, Uetz P, Xenarios I, Hermjakob H.

Nat Methods. 2012 Apr;9(4):345-50. doi: 10.1038/nmeth.1931. Erratum in: Nat Methods. 2012 Jun;9(6):626. Brinkman, Fiona [corrected to Brinkman, Fiona S L]; Hancock, Robert [corrected to Hancock, Robert E W].

46.

Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.

Akbari M, Shah S, Velayos FS, Mahadevan U, Cheifetz AS.

Inflamm Bowel Dis. 2013 Jan;19(1):15-22. doi: 10.1002/ibd.22948. Review.

PMID:
22434610
47.

Cytokine profiles in peripheral blood of children and adults with Crohn disease.

Pak S, Holland N, Garnett EA, Mileti E, Mahadevan U, Beckert R, Kanwar B, Heyman MB.

J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):769-75. doi: 10.1097/MPG.0b013e3182455bb3.

48.

The IntAct molecular interaction database in 2012.

Kerrien S, Aranda B, Breuza L, Bridge A, Broackes-Carter F, Chen C, Duesbury M, Dumousseau M, Feuermann M, Hinz U, Jandrasits C, Jimenez RC, Khadake J, Mahadevan U, Masson P, Pedruzzi I, Pfeiffenberger E, Porras P, Raghunath A, Roechert B, Orchard S, Hermjakob H.

Nucleic Acids Res. 2012 Jan;40(Database issue):D841-6. doi: 10.1093/nar/gkr1088. Epub 2011 Nov 24.

49.

Efficacy of anti-TNF therapies in refractory severe microscopic colitis.

Esteve M, Mahadevan U, Sainz E, Rodriguez E, Salas A, Fernández-Bañares F.

J Crohns Colitis. 2011 Dec;5(6):612-8. doi: 10.1016/j.crohns.2011.05.001. Epub 2011 Jun 8.

PMID:
22115383
50.

Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist.

Leung Y, Heyman MB, Mahadevan U.

Inflamm Bowel Dis. 2011 Oct;17(10):2169-73. doi: 10.1002/ibd.21576. Epub 2010 Dec 16.

Supplemental Content

Loading ...
Support Center